Individual Treatment Effects & Personalized Access Read more about Individual Treatment Effects & Personalized Access
Toward individualized pharmaceutical care of East Asians: the value of genetic testing for polymorphisms in drug-metabolizing genes Read more about Toward individualized pharmaceutical care of East Asians: the value of genetic testing for polymorphisms in drug-metabolizing genes
A Translation Table for Patient-Centered Comparative Effectiveness Research-- Guidance to Improve the Value of Research for Clinical and Health Policy Decision-Making Read more about A Translation Table for Patient-Centered Comparative Effectiveness Research-- Guidance to Improve the Value of Research for Clinical and Health Policy Decision-Making
2013 Comparative Effectiveness Research and the Environment for Health Care Decision-Making Read more about 2013 Comparative Effectiveness Research and the Environment for Health Care Decision-Making
Comparative Effectiveness Research: Do Employers Care? What Will They Do? What About Productivity? Read more about Comparative Effectiveness Research: Do Employers Care? What Will They Do? What About Productivity?
The Myth of Average: Why Individual Patient Differences Matter Read more about The Myth of Average: Why Individual Patient Differences Matter
Deciphering Heterogeneity: The Good, The Bad and The Different Read more about Deciphering Heterogeneity: The Good, The Bad and The Different
The Emerging Relevance of Heterogeneity of Treatment Effect in Clinical Care: A Study Using Stage IV Prostate Cancer as a Model Read more about The Emerging Relevance of Heterogeneity of Treatment Effect in Clinical Care: A Study Using Stage IV Prostate Cancer as a Model
The Good, the Bad, and the Different: A Primer on Aspects of Heterogeneity of Treatment Effects Read more about The Good, the Bad, and the Different: A Primer on Aspects of Heterogeneity of Treatment Effects
Supporting Consumer Access to Specialty Medications Through Value-Based Insurance Design Read more about Supporting Consumer Access to Specialty Medications Through Value-Based Insurance Design